---
abstract_fix_date: '2025-10-21T17:30:38.123953'
abstract_fixed: true
acquisition_date: '2025-10-21T16:20:55.165025'
acquisition_method: paperscraper_automated
audience:
- professional
- researcher
authors: '[''Lea SEiland'', ''Brooke LGildon'']'
conditions:
- adhd
content_type: research_paper
doi: 10.5863/1551-6776-29.2.107
journal: 'The journal of pediatric pharmacology and therapeutics : JPPT : the official
  journal of PPAG'
keywords:
- adhd
- neurochemistry
- pubmed
patient_friendly: false
primary_category: neurochemistry/other-neurotransmitters
publication_date: '2024-04-10'
reading_level: academic
search_priority: standard
search_query: norepinephrine neurodevelopmental
search_tags:
- adhd
- neurochemistry
- pubmed
- research
- academic
source: PUBMED via Paperscraper
title: Diagnosis and Treatment of ADHD in the Pediatric Population.
topics:
- adhd
type: research_paper
---

# Diagnosis and Treatment of ADHD in the Pediatric Population.

**Authors:** ['Lea SEiland', 'Brooke LGildon']

**Journal:** The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

**Publication Date:** 2024-04-10

**DOI:** 10.5863/1551-6776-29.2.107

## Abstract

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood with approximately 6 million children (age 3 to 17 years) ever diagnosed based on data from 2016-2019. ADHD is characterized by a constant pattern of inattention and/or hyperactivity-impulsivity symptoms that interferes with development or functioning. Specific criteria from the 

---

## Research Details

**Source:** PUBMED
**Category:** neurochemistry
**Primary Topics:** adhd
**Search Query:** norepinephrine neurodevelopmental
**Acquisition Date:** 2025-10-21

*This paper was automatically acquired and processed for the neurodevelopmental disorders knowledge base.*
